The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
ScarHypertrophic ScarMammary Disorder
Interventions
DRUG

Botulinum Toxins

We will be comparing botulinum toxin following breast reduction surgery to placebo injection. We will then compare photos of each breast reduction scar at set intervals following surgery.

OTHER

Normal saline

Normal saline will serve as the placebo control on the contralateral breast

Trial Locations (1)

48202

Henry Ford Health System, Detroit

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Galderma R&D

INDUSTRY

lead

Henry Ford Health System

OTHER

NCT03887377 - The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation | Biotech Hunter | Biotech Hunter